IDEAYA Biosciences (IDYA) Revenue (2020 - 2026)

IDEAYA Biosciences has disclosed Revenue across 7 years of filings, most recently posting $6.6 million for Q1 2026.

• Revenue for Q1 2026 came in at $6.6 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $232.3 million (changed N/A YoY), and the FY2025 annual result was $218.7 million, up 3024.43% from the prior year.
• Revenue came in at $6.6 million for Q1 2026 at IDEAYA Biosciences, down from $10.9 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $207.8 million in Q3 2025 to a low of $3.5 million in Q2 2023.
• The 5-year median for Revenue is $7.4 million (2023), against an average of $25.5 million.
• Across the five-year window, Revenue soared 230.87% in 2022 and plunged 72.94% in 2023, its largest moves.
• IDEAYA Biosciences' Revenue stood at $4.0 million in 2022, then dropped by 2.49% to $3.9 million in 2023, then surged by 78.48% to $7.0 million in 2024, then soared by 55.37% to $10.9 million in 2025, then slumped by 39.68% to $6.6 million in 2026.
• The last three Revenue figures came in at $6.6 million (Q1 2026), $10.9 million (Q4 2025), and $207.8 million (Q3 2025), per Business Quant data.